TAB2 and Hepatic fibrosis: This action on TAB2, which recognizes K63-linked ubiquitin chains of RIP1 in TNF-α signaling or TRAF6 in IL-1β signaling, consequently inhibits the TAK1-MAPK cascade, a pathway critical in liver fibrosis progression (95, 96).